Published in Elife on December 19, 2015
Cellular Aging Contributes to Failure of Cold-Induced Beige Adipocyte Formation in Old Mice and Humans. Cell Metab (2016) 2.04
Targeting cellular senescence prevents age-related bone loss in mice. Nat Med (2017) 1.39
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell (2016) 1.06
Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. Circ Res (2016) 0.98
Molecular pathology endpoints useful for aging studies. Ageing Res Rev (2016) 0.89
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest (2017) 0.84
Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. Exp Gerontol (2016) 0.83
Cellular senescence mediates fibrotic pulmonary disease. Nat Commun (2017) 0.81
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) (2017) 0.80
Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes. J Gerontol A Biol Sci Med Sci (2016) 0.78
The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches. Annu Rev Cell Dev Biol (2016) 0.78
Senotherapy: growing old and staying young? Pflugers Arch (2017) 0.75
Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction. Pharmacol Res (2016) 0.75
Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty. Physiology (Bethesda) (2017) 0.75
Diet-induced weight loss is sufficient to reduce senescent cell number in white adipose tissue of weight-cycled mice. Nutr Healthy Aging (2016) 0.75
Silencing of the small GTPase DIRAS3 induces cellular senescence in human white adipose stromal/progenitor cells. Aging (Albany NY) (2017) 0.75
p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging (Albany NY) (2017) 0.75
The Clinical Potential of Senolytic Drugs. J Am Geriatr Soc (2017) 0.75
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 12.14
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med (2012) 10.07
Dynamics of fat cell turnover in humans. Nature (2008) 9.80
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med (2012) 9.69
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol (2002) 8.89
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med (2010) 8.77
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A (2003) 6.46
Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell (1999) 4.89
Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol (2004) 4.69
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood (2010) 4.33
CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci U S A (1994) 3.66
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest (2002) 3.28
A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98
Age-related changes in total and regional fat distribution. Ageing Res Rev (2009) 2.88
Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes (2011) 2.67
Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab (2010) 2.58
A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One (2010) 2.38
Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A (2010) 2.17
Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16
Mechanisms of insulin resistance in aging. J Clin Invest (1983) 2.00
Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab (2013) 1.94
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci U S A (2008) 1.89
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell (2015) 1.88
Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalpha. J Biol Chem (1999) 1.88
Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp Gerontol (2007) 1.81
Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem (2006) 1.70
Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J (2007) 1.65
The biology of activin: recent advances in structure, regulation and function. J Endocrinol (2009) 1.64
The intersection between aging and cardiovascular disease. Circ Res (2012) 1.61
Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem (2009) 1.60
A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clin Nutr (2005) 1.60
A senescent cell bystander effect: senescence-induced senescence. Aging Cell (2012) 1.54
Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol (2001) 1.40
Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev (2006) 1.38
Intracellular lipid-binding proteins and their genes. Annu Rev Nutr (1997) 1.34
Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Physiol (1990) 1.33
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding. EMBO J (2009) 1.33
Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes (2010) 1.31
Perilipin1 promotes unilocular lipid droplet formation through the activation of Fsp27 in adipocytes. Nat Commun (2013) 1.31
Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab (2007) 1.21
Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab (2015) 1.20
Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb. J Biol Chem (2010) 1.16
Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging (Albany NY) (2014) 1.15
Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem (2006) 1.13
Aging, depot origin, and preadipocyte gene expression. J Gerontol A Biol Sci Med Sci (2010) 1.13
Saturated with fat: new perspectives on lipotoxicity. Curr Opin Clin Nutr Metab Care (2009) 1.09
JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci U S A (2015) 1.03
Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Am J Physiol Endocrinol Metab (2007) 1.01
White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol (2014) 1.00
The role of JAK-STAT signaling in adipose tissue function. Biochim Biophys Acta (2013) 0.99
Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech Ageing Dev (2005) 0.98
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity. Diabetes (2015) 0.98
Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol (2012) 0.91
Ncb5or deficiency increases fatty acid catabolism and oxidative stress. J Biol Chem (2011) 0.90
Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. Am J Physiol Endocrinol Metab (2006) 0.90
Cell autonomous lipin 1 function is essential for development and maintenance of white and brown adipose tissue. Mol Cell Biol (2012) 0.90
Adipogenic differentiation is impaired in replicative senescent human subcutaneous adipose-derived stromal/progenitor cells. J Gerontol A Biol Sci Med Sci (2013) 0.85
Adipogenesis of the mesenchymal stromal cells and bone oedema in rheumatoid arthritis. Clin Exp Rheumatol (2012) 0.83